Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2010
02/04/2010US20100029605 Compounds and compositions as protein kinase inhibitors
02/04/2010US20100029598 Extended Benzamide Derivatives as Modulators of the EP2 Receptor
02/04/2010US20100028329 Method for producing glycosylated indole compound and antibody against the compound
02/04/2010US20100028299 Methods and compositions of treating a flaviviridae family viral infection
02/04/2010CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010CA2731919A1 New compounds
02/04/2010CA2731909A1 5-alkynyl-pyrimidines
02/04/2010CA2731403A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
02/04/2010CA2729581A1 Fluorinated heteroaryls
02/03/2010EP2149563A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
02/03/2010EP2149554A1 Indolyamides as modulators for an EP2 receptor
02/03/2010EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors
02/03/2010EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors
02/03/2010EP2148931A2 Drug discovery methods for aurora kinase inhibitors
02/03/2010EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
02/03/2010EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
02/03/2010EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
02/03/2010EP2148853A1 Insecticidal aryl pyrrolidines
02/03/2010EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents
02/03/2010EP1511742B1 Kinase inhibitors
02/03/2010CN101641349A Pyrimidine substituted macrocyclic HCV inhibitors
02/02/2010US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
02/02/2010US7655797 Intermediates for making 2,4-pyrimidinediamine compounds
02/02/2010US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
02/02/2010US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
02/02/2010US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
02/02/2010US7655661 Prodrugs of CC-1065 analogs
02/02/2010US7655660 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide
02/02/2010US7655652 Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
02/02/2010US7655649 Inhibitors of Akt activity
02/02/2010US7655217 Using water soluble dyes; fluorescence contrast agent
02/02/2010CA2485685C Calcium receptor modulating agents
02/02/2010CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
02/02/2010CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
02/02/2010CA2316172C Indole derivatives as inhibitors of factor xa
02/02/2010CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments
02/02/2010CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
01/2010
01/28/2010WO2010011949A2 Caprolactam monomers and copolymers made therefrom
01/28/2010WO2010011924A2 Monomers derived from alpha-or beta-amino-e-caprolactam and polymers made therefrom
01/28/2010WO2010011864A2 Alpha-helix mimetic with functionalized pyridazine
01/28/2010WO2010011834A2 Sunitinib and salts thereof and their polymorphs
01/28/2010WO2010011821A2 Dual-acting antihypertensive agents
01/28/2010WO2010011666A2 Indoline scaffold shp-2 inhibitors and cancer treatment method
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010011538A1 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010WO2010011325A2 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling
01/28/2010WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
01/28/2010WO2010010909A1 Therapeutic agent for chronic renal failure
01/28/2010WO2010010458A1 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
01/28/2010WO2010010454A2 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt
01/28/2010WO2010010154A1 3,4-diarylpyrazoles as protein kinase inhibitors
01/28/2010WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants
01/28/2010WO2009140089A3 Sulfone compounds which modulate the cb2 receptor
01/28/2010WO2009123714A3 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
01/28/2010WO2009120094A3 Substituted pyrimidines and triazines and their use in cancer therapy
01/28/2010WO2009101018A3 3-alkyl-piperazine derivatives and uses thereof
01/28/2010US20100022783 Cyclohexanecarboxylic acid compound
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022769 Novel polynitrogenated systems as anti-hiv agents
01/28/2010US20100022599 imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents
01/28/2010US20100022598 Substituted inmidazoles as bombesin receptor subtype-3 modulators
01/28/2010US20100022559 Bisoximes as fungicides
01/28/2010US20100022557 Radioprotector compounds and related methods
01/28/2010US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators
01/28/2010US20100022549 Alpha-helix mimetic with functionalized pyridazine
01/28/2010US20100022540 Triazole derivatives ii
01/28/2010US20100022538 5-fluoro pyrimidine derivatives
01/28/2010US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use
01/28/2010US20100022529 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010US20100022528 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
01/28/2010US20100022516 4,5-Disubstituted-2-aryl pyrimidines
01/28/2010US20100022514 Heterocycle Compounds and Methods of Use Thereof
01/28/2010US20100022507 Aminopyrimidines useful as inhibitors of protein kinases
01/28/2010US20100022505 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
01/28/2010US20100022476 Pyrazolylamino substituted quinazoles for the treatment of cancer
01/28/2010US20100019657 Novel organic electroluminescent compounds and organic electroluminescent device using the same
01/28/2010CA2731773A1 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010CA2731605A1 Sunitinib and salts thereof and their polymorphs
01/28/2010CA2731146A1 3,4-diarylpyrazoles as protein kinase inhibitors
01/28/2010CA2730500A1 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid deri vatives useful in the treatment of autoimmune and inflammatory disorders
01/28/2010CA2730288A1 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
01/28/2010CA2728629A1 Adamantyl diamide derivatives and uses of same
01/27/2010EP2146984A1 Hepatitis c virus inhibitors
01/27/2010EP2146982A2 Aminopyrimidines useful as kinase inhibitors
01/27/2010EP2146971A1 Novel benzamidine derivatives useful as potassium channel modulators
01/27/2010EP2146969A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
01/27/2010EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives
01/27/2010EP2146964A2 Ethers of naphtalene carboxylic acid amides as cancer cure
01/27/2010EP2146963A2 Dual-acting antihypertensive agents
01/27/2010EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
01/27/2010EP2146720A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
01/27/2010EP2146718A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
01/27/2010EP2146717A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
01/27/2010EP2146716A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
01/27/2010EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
01/27/2010EP2044051B1 Pyridine and pyrazine derivatives as mnk kinase inhibitors
01/27/2010EP1893581B1 Substituted arylpyrazoles for use against parasitites
01/27/2010EP1656353B1 Gabanergic modulators
01/27/2010EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity
01/27/2010CN101633656A Method for synthesizing candesartan cilexetil as candesartan medicament